Key Takeaways BASFY signed a deal to divest its optical brightening agent business as part of its Winning Ways strategy. The sale includes the Monthey, Switzerland facility and about 80 employees, with financial terms undisclosed. Catexel will integrate the business into its specialty chemicals portfolio, with closing expected in Q1 2026.BASF SE (BASFY) has signed a definitive agreement to divest its optical brightening agent business to Catexel, aligning with the company’s ongoing portfolio transformation ...